ArtiFascia First-in-Human clinical study has been successfully completed

  • ArtiFascia First-in-Human clinical study has been successfully completed
  • 6 patients were implanted with ArtiFascia with a 6 month follow-up period
  • No device related adverse events were reported during the entire study
  • No CSF leakage events occurred

Share This Post

we want to hear from you